---
title: Clarenta vs Optum Life Sciences
slug_a: comac-medical
slug_b: optum
site: cro
review_signal_gate: closed
canonical_path: /compare/comac-medical/optum
generated_by: BioBM Editorial AI
---

# Clarenta vs Optum Life Sciences

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Clarenta (comac-medical) is listed for cro. Clarenta (formerly Comac Medical Group) is a pan-European CRO offering full-service trial delivery and early-phase studies, including first-in-human and PK work. It runs a Phase I unit in Sofia and has depth in oncology and rare diseases.

Services: 8. Modalities: 0. Indications: 7. Locations: 10. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (10).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Optum Life Sciences (optum) is listed for cro. Optum is a leading healthcare company that provides integrated medical, pharmacy, and financial services across the United States. Founded in April 2011 as a UnitedHealth Group company, Optum serves more than 120 million people through a network of doctors and care teams.

Services: 4. Modalities: 0. Indications: 0. Locations: 21. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (21).

Review summary: Review summary withheld until site-level review gate opens.